PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Shanghai Frontiers Science Center of TCM Chemical Biology, Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.\', \'Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.\', \'Shanghai Frontiers Science Center of TCM Chemical Biology, Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. Electronic address: tianping@shutcm.edu.cn.\', \'Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. Electronic address: geguangbo@dicp.ac.cn.\', \'Shanghai Frontiers Science Center of TCM Chemical Biology, Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. Electronic address: gaodingding@shutcm.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0223-5234(21)00879-510.1016/j.ejmech.2021.114030
?:doi
?:hasPublicationType
?:journal
  • European journal of medicinal chemistry
is ?:pmid of
?:pmid
?:pmid
  • 34883292
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.266
?:rankingScore_hIndex
  • 127
is ?:relation_isRelatedTo_publication of
?:title
  • Discovery of 9,10-dihydrophenanthrene derivatives as SARS-CoV-2 3CLpro inhibitors for treating COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all